Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineered T7 RNA polymerase to improve mRNA capping efficiency and reduce dsRNA generation during <i>in vitro</i> transcription.

Molecular therapy. Advances·2026
Same author

CAR-T-drug conjugate against solid tumor.

bioRxiv : the preprint server for biology·2026
Same author

Endovascular thrombectomy for acute stroke: evolving eligibility criteria and adjunct therapies.

The Lancet. Neurology·2025
Same author

Brain-wide Genome Editing via STEP-RNPs for Treatment of Angelman Syndrome.

bioRxiv : the preprint server for biology·2025
Same author

Engineered chimeric T7 RNA polymerase improves salt tolerance and reduces dsRNA impurity generation during in vitro transcription of mRNA.

Nucleic acids research·2025
Same author

RCC2 and CD24 cooperate to modulate prostate cancer progression through vimentin ubiquitination and β-catenin activation.

The Journal of clinical investigation·2025

Related Experiment Video

Updated: May 27, 2026

Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry
08:51

Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry

Published on: March 1, 2013

Biodegradable poly(amine-co-ester) terpolymers for targeted gene delivery.

Jiangbing Zhou1, Jie Liu, Christopher J Cheng

  • 1Department of Biomedical Engineering, Yale University, New Haven, Connecticut 06511, USA.

Nature Materials
|December 6, 2011
PubMed
Summary

Researchers developed novel, low-charge synthetic polymers for efficient and safe gene delivery. These terpolymers show promise for in vivo applications, outperforming existing commercial reagents with minimal toxicity.

More Related Videos

Methionine Functionalized Biocompatible Block Copolymers for Targeted Plasmid DNA Delivery
08:09

Methionine Functionalized Biocompatible Block Copolymers for Targeted Plasmid DNA Delivery

Published on: August 6, 2019

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles
09:01

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles

Published on: September 27, 2013

Related Experiment Videos

Last Updated: May 27, 2026

Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry
08:51

Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry

Published on: March 1, 2013

Methionine Functionalized Biocompatible Block Copolymers for Targeted Plasmid DNA Delivery
08:09

Methionine Functionalized Biocompatible Block Copolymers for Targeted Plasmid DNA Delivery

Published on: August 6, 2019

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles
09:01

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles

Published on: September 27, 2013

Area of Science:

  • Polymer Chemistry
  • Biomaterials Science
  • Gene Therapy Vectors

Background:

  • Synthetic polycationic vectors are effective for in vitro gene delivery but exhibit toxicity in vivo due to high charge density.
  • Developing safe and efficient non-viral gene delivery vectors remains a significant challenge in biomedical research.

Purpose of the Study:

  • To synthesize and characterize novel high molecular weight terpolymers with low charge density for gene delivery.
  • To evaluate the in vitro and in vivo gene delivery efficiency and toxicity of these terpolymers.
  • To investigate the relationship between terpolymer properties (molecular weight, hydrophobicity, charge density) and gene delivery performance.

Main Methods:

  • Terpolymers were synthesized using enzyme-catalyzed copolymerization of lactone, dialkyl diester, and amino diol.
  • Hydrophobicity was modulated by altering lactone content and selecting specific lactone ring sizes.
  • In vitro gene delivery efficiency was compared against commercial reagents like Polyethylenimine (PEI) and Lipofectamine 2000.
  • In vivo studies involved targeted delivery of the TRAIL gene to tumor xenografts to assess therapeutic efficacy and toxicity.

Main Results:

  • Synthesized terpolymers demonstrated efficient gene delivery, with some exceeding the performance of commercial transfection reagents.
  • Adjusting lactone content and ring size allowed for tuning of terpolymer hydrophobicity.
  • Targeted delivery of the TRAIL gene using a specific terpolymer resulted in significant tumor growth inhibition.
  • The developed terpolymers exhibited minimal toxicity in both in vitro and in vivo models.

Conclusions:

  • High molecular weight and increased hydrophobicity can compensate for low charge density in gene delivery vectors.
  • These novel terpolymers represent a promising platform for safe and effective non-viral gene therapy.
  • The findings offer a new strategy for designing advanced gene delivery systems with improved therapeutic indices.